View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 27, 2020

ARDS treatments are important for severe Covid-19

By Victoria Smith

As the Covid-19 pandemic continues to spread, over 2.7 million cases have been confirmed, as well as 193,000 deaths. Pharmaceutical companies are continuing to explore treatments to alleviate the symptoms of the disease and improve the chances of survival on severely affected patients.

A number of drugs are currently being investigated for their ability to reduce one of the primary causes of death in patients, acute respiratory distress syndrome. Click here to read more.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy